REPORT SCOPE
INTRODUCTION
STUDY OBJECTIVES
BCC’s goal in conducting this study is to provide an overview of the current and future characteristics of the global market for antiemetic agents. The key objective is to present a comprehensive analysis of the current market and its future direction and the antiemetics market as an important agent as adjunct therapy for cancer patients and also other therapeutic arenas to control emesis.
This report explores present and future strategies within the antiemetic market, reason for emesis, and types of antiemetic agents used to control nausea or vomiting. The improvisation of the market, and the setbacks and the needs of the market are discussed in this report. The causes of emesis, usage of antiemetics and the types of products available to treat nausea and vomiting of each category of antiemetics are also portrayed in this report.
A detailed analysis of the antiemetic industry structure has been conducted. The revenues are broken down by region. Sales figures are estimated for the 5 year period from the end of 2010 through 2015.
Applications for antiemetics are also discussed separately in the report, with emphasis on the usage in chemotherapy-induced nausea and vomiting (CINV), post-radiotherapy nausea and vomiting, and post-operative nausea and vomiting (PONV), etc. The report also covers significant patents and their allotments in each category.
REASONS FOR DOING THIS STUDY
Emesis itself is not a disease but is stressful enough to discourage a patient, especially a patient dealing with cancer therapies. The antiemetics market has seen advancement in modern medicine. R&D spending, along with increasing competition, patent expiries, new technologies, and an international marketplace are directing this new direction. The antiemetics market has seen almost a constant growth except some setbacks in 5-HT2 category in 2009, due to the general economic downturn, but new advances and the need for good pharmacological activity of antiemetic products are influencing the market to grow. This study looks at almost all the systems affected by these factors.
Acquisition strategies and collaborations by companies are also covered in this report. This study also discusses the strength and weaknesses of each system/ technology in light of the new technologies, growing competition, and changing customer needs.
INTENDED AUDIENCE
This study contributes to the areas of market growth in the antiemetic industry from the point of view of manufacturers and users. Biotechnological companies, physicians, the pharmaceutical and biopharmaceutical industries, hospitals, and research institutes will find this study to be of interest.
SCOPE OF THE STUDY
The scope of this study encompasses the biotechnology, pharmaceutical, and medical markets. BCC analyzes each market and its applications by its need for development of new medications, regulatory environment, technology involved, market projections, and market share. Technological issues include the latest trends and developments.
METHODOLOGY
Both primary and secondary research methodologies were used in preparing this market research report. BCC conducted a comprehensive search of the literature, which included technical newsletters and journals, and many other sources. Data were collected through interviews and correspondence with various analytical/chemical/pharmaceutical/biotechnical experts. Projections were based on estimates such as the current number of end users, potential end users, mergers and acquisitions, and market trends.
INFORMATION SOURCES
Many companies within the industry were contacted to obtain data for this study. Included were manufacturers and end users of biopharmaceutical and pharmaceutical products, through their production, research, and contract manufacturing/research lines. Data were gathered from various industry sources. BCC spoke with officials and physicians within the industry, consulted newsletters, company literature, product literature, and a host of technical articles, journals, indexes, and abstracts. Exhaustive investigations of databases by key terminology were completed. In addition, data were compiled from current financial, trade, and government sources.
ABOUT THE AUTHOR
Shalini S. Dewan holds a master’s degree in pharmaceutical chemistry. Among the research topics she has covered are studies on compounds of potential pharmaceutical interest from ibuprofen and 2-naphthyl acetic acid. Shalini was awarded a Gold Medal by the Prime Minister of India for her work and has worked with top companies in India and in the U.S. Some of her other reports with BCC are MST034C Reagents for Chromatography; IAS004B Spectroscopy, An Enduring Market; PHM006G Advanced Drug Delivery Systems: New Developments, New Technologies; PHM040A Orthopedic Drugs, Implants and Devices; HLC040C Medical Imaging Reagents and Analysis Equipment; PHM047A Pharmaceutical Regulatory Industry; and BIO014F The Dynamic Media, Sera and Reagent Market in Biotechnology.
BCC ONLINE SERVICES
BCC offers an online information retrieval service. BCC’s home page, located at www.bccresearch.com, enables readers to:
- Examine BCC’s complete catalog of Market Research Reports and place direct orders
- Subscribe to any of BCC’s many industry newsletters
- Read announcements of recently published reports and newly launched newsletters
- Register for BCC’s well-known conferences
- Request additional information on any BCC product
- Take advantage of special offers
DISCLAIMER
The information developed in this report is intended to be as reliable as possible at the time of publication and of a professional nature. This information does not constitute managerial, legal, or accounting advice; nor should it serve as a corporate policy guide, laboratory manual, or an endorsement of any product, as much of the information is speculative in nature. The author assumes no responsibility for any loss or damage that might result from reliance on the reported information or its use.
